These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 20066725

  • 1. 3-year follow-up of 100 consecutive coronary bifurcation lesions treated with Taxus stents and the crush technique.
    Chue CD, Routledge HC, Ludman PF, Townend JN, Epstein AC, Buller NP, Doshi SN.
    Catheter Cardiovasc Interv; 2010 Mar 01; 75(4):605-13. PubMed ID: 20066725
    [Abstract] [Full Text] [Related]

  • 2. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).
    Ellis SG, Stone GW, Cox DA, Hermiller J, O'Shaughnessy C, Mann T, Turco M, Caputo R, Bergin PJ, Bowman TS, Baim DS, TAXUS IV Investigators.
    JACC Cardiovasc Interv; 2009 Dec 01; 2(12):1248-59. PubMed ID: 20129552
    [Abstract] [Full Text] [Related]

  • 3. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
    Beijk MA, Klomp M, van Geloven N, Koch KT, Henriques JP, Baan J, Vis MM, Tijssen JG, Piek JJ, de Winter RJ.
    Catheter Cardiovasc Interv; 2011 Aug 01; 78(2):189-95. PubMed ID: 21542109
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
    Kervinen K, Niemelä M, Romppanen H, Erglis A, Kumsars I, Maeng M, Holm NR, Lassen JF, Gunnes P, Stavnes S, Jensen JS, Galløe A, Narbute I, Sondore D, Christiansen EH, Ravkilde J, Steigen TK, Mannsverk J, Thayssen P, Hansen KN, Helqvist S, Vikman S, Wiseth R, Aarøe J, Jokelainen J, Thuesen L, Nordic PCI Study Group.
    JACC Cardiovasc Interv; 2013 Nov 01; 6(11):1160-5. PubMed ID: 24262616
    [Abstract] [Full Text] [Related]

  • 8. Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions.
    Yang HM, Tahk SJ, Woo SI, Lim HS, Choi BJ, Choi SY, Yoon MH, Park JS, Zheng M, Hwang GS, Kang SJ, Shin JH.
    Catheter Cardiovasc Interv; 2009 Jul 01; 74(1):76-84. PubMed ID: 19360861
    [Abstract] [Full Text] [Related]

  • 9. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
    Wöhrle J, Werner GS.
    Catheter Cardiovasc Interv; 2013 Apr 01; 81(5):793-9. PubMed ID: 22511572
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease.
    De Luca L, Altamura L, Corvo P, De Persio G, Ghini AS, Petrolini A, Aurigemma C, Tomai F.
    Catheter Cardiovasc Interv; 2011 May 01; 77(6):765-72. PubMed ID: 21413124
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Four-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial.
    Garg S, Serruys PW, Miquel-Hebert K, SPIRIT II Investigators.
    Catheter Cardiovasc Interv; 2011 Jun 01; 77(7):1012-7. PubMed ID: 20824770
    [Abstract] [Full Text] [Related]

  • 15. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.
    Brilakis ES, Lasala JM, Cox DA, Berger PB, Bowman TS, Starzyk RM, Dawkins KD.
    JACC Cardiovasc Interv; 2010 Jul 01; 3(7):742-50. PubMed ID: 20650436
    [Abstract] [Full Text] [Related]

  • 16. Incidence and predictors of very late (>or=4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-Late registry.
    Costa JR, Sousa A, Moreira AC, Costa RA, Cano M, Maldonado G, Campos C, Carballo M, Pavanello R, Sousa JE.
    JACC Cardiovasc Interv; 2010 Jan 01; 3(1):12-8. PubMed ID: 20129562
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C, Onuma Y, Magro M, de Boer S, Battes L, van Domburg RT, Boersma E, Serruys PW, Interventional Cardiologists of the Thoraxcenter (2000-2005).
    Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):41-9. PubMed ID: 20310019
    [Abstract] [Full Text] [Related]

  • 19. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.
    Lasala JM, Cox DA, Dobies D, Baran K, Bachinsky WB, Rogers EW, Breall JA, Lewis DH, Song A, Starzyk RM, Mascioli SR, Dawkins KD, Baim DS, ARRIVE 1 and ARRIVE 2 Participating Physicians.
    Circ Cardiovasc Interv; 2009 Aug 01; 2(4):285-93. PubMed ID: 20031730
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.